Use of an Electronic Health Record-Embedded Glycemic Management Protocol to Improve Perioperative Glucose Control in People With Diabetes.

IF 3.7 Q2 ENDOCRINOLOGY & METABOLISM
Shubham Agarwal, Jason F Shiffermiller, Troy S Wildes, Melissa A McKnight, Matthew J Anderson, Elizabeth R Lyden, Andjela T Drincic
{"title":"Use of an Electronic Health Record-Embedded Glycemic Management Protocol to Improve Perioperative Glucose Control in People With Diabetes.","authors":"Shubham Agarwal, Jason F Shiffermiller, Troy S Wildes, Melissa A McKnight, Matthew J Anderson, Elizabeth R Lyden, Andjela T Drincic","doi":"10.1177/19322968251386044","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Perioperative hyperglycemia in people with diabetes is associated with increased morbidity, mortality, and health care costs. Despite guideline recommendations to institute interventions to reduce hyperglycemia, standardized protocols that integrate into clinical workflows are lacking. In this article, we evaluate the efficacy of a digitally embedded, glycemic management protocol in people with diabetes undergoing surgery.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of a quality improvement study conducted at a tertiary-care academic hospital. Adults with diabetes undergoing noncardiac surgery with more than two hours of procedure time were included. A multidisciplinary protocol was implemented guiding insulin administration and glucose monitoring across preoperative, intraoperative, and post-anesthesia care unit (PACU) phases. People undergoing surgery during one year before protocol implementation were compared with those in the year after. The primary outcome was the proportion of intraoperative glucose readings within 70 to 180 mg/dL. Secondary outcomes included glucose control in other perioperative phases, hypoglycemia incidence, and 30-day postoperative complications.</p><p><strong>Results: </strong>Among 1254 adults (634 pre-intervention, 620 post-intervention), the mean proportion of intraoperative glucose values in the target range of 70 to 180 mg/dL showed a modest yet statistically significant improvement after protocol implementation (0.65 vs 0.72, <i>P</i> = .021). We found a reduced risk of hypoglycemia in the preoperative phase (3.7% vs 1.3%, <i>P</i> = .007) and no increased risk of hypoglycemia in the intraoperative or PACU phases. An increase in glucose monitoring and intravenous insulin use was noted across all phases of care (<i>P</i> < .001).</p><p><strong>Conclusions: </strong>Implementation of a digitally embedded perioperative glycemic management protocol improved glucose monitoring and intraoperative glucose control without increasing hypoglycemia. These findings support the safe and effective use of the protocol across surgical specialties and case urgencies, supporting the value of integrating decision support tools into clinical workflows.</p>","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":" ","pages":"254-261"},"PeriodicalIF":3.7000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13044412/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968251386044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Perioperative hyperglycemia in people with diabetes is associated with increased morbidity, mortality, and health care costs. Despite guideline recommendations to institute interventions to reduce hyperglycemia, standardized protocols that integrate into clinical workflows are lacking. In this article, we evaluate the efficacy of a digitally embedded, glycemic management protocol in people with diabetes undergoing surgery.

Methods: We conducted a retrospective analysis of a quality improvement study conducted at a tertiary-care academic hospital. Adults with diabetes undergoing noncardiac surgery with more than two hours of procedure time were included. A multidisciplinary protocol was implemented guiding insulin administration and glucose monitoring across preoperative, intraoperative, and post-anesthesia care unit (PACU) phases. People undergoing surgery during one year before protocol implementation were compared with those in the year after. The primary outcome was the proportion of intraoperative glucose readings within 70 to 180 mg/dL. Secondary outcomes included glucose control in other perioperative phases, hypoglycemia incidence, and 30-day postoperative complications.

Results: Among 1254 adults (634 pre-intervention, 620 post-intervention), the mean proportion of intraoperative glucose values in the target range of 70 to 180 mg/dL showed a modest yet statistically significant improvement after protocol implementation (0.65 vs 0.72, P = .021). We found a reduced risk of hypoglycemia in the preoperative phase (3.7% vs 1.3%, P = .007) and no increased risk of hypoglycemia in the intraoperative or PACU phases. An increase in glucose monitoring and intravenous insulin use was noted across all phases of care (P < .001).

Conclusions: Implementation of a digitally embedded perioperative glycemic management protocol improved glucose monitoring and intraoperative glucose control without increasing hypoglycemia. These findings support the safe and effective use of the protocol across surgical specialties and case urgencies, supporting the value of integrating decision support tools into clinical workflows.

使用电子健康记录嵌入式血糖管理方案改善糖尿病患者围手术期血糖控制
背景:糖尿病患者围手术期高血糖与发病率、死亡率和医疗费用增加有关。尽管指南建议制定干预措施以降低高血糖,但缺乏整合到临床工作流程中的标准化方案。在这篇文章中,我们评估了数字化嵌入式血糖管理方案在接受手术的糖尿病患者中的疗效。方法:我们对在一家三级保健学术医院进行的质量改进研究进行了回顾性分析。接受非心脏手术且手术时间超过2小时的成人糖尿病患者也包括在内。实施多学科方案,指导术前、术中和麻醉后护理单位(PACU)阶段的胰岛素给药和血糖监测。在方案实施前一年接受手术的人与实施后一年接受手术的人进行比较。主要结局是术中血糖读数在70 ~ 180mg /dL范围内的比例。次要结局包括其他围手术期血糖控制、低血糖发生率和术后30天并发症。结果:1254名成人(干预前634人,干预后620人)中,术中血糖值在70 ~ 180 mg/dL目标范围内的平均比例在方案实施后略有改善,但有统计学意义(0.65 vs 0.72, P = 0.021)。我们发现术前低血糖风险降低(3.7% vs 1.3%, P = .007),术中或PACU期低血糖风险未增加。血糖监测和静脉注射胰岛素的使用在治疗的各个阶段都有所增加(P < 0.001)。结论:数字嵌入式围手术期血糖管理方案的实施改善了血糖监测和术中血糖控制,而不会增加低血糖。这些发现支持在外科专科和紧急病例中安全有效地使用该方案,支持将决策支持工具整合到临床工作流程中的价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Diabetes Science and Technology
Journal of Diabetes Science and Technology Medicine-Internal Medicine
CiteScore
7.50
自引率
12.00%
发文量
148
期刊介绍: The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书